Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03298516 |
Title | A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Genentech, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | Duarte | California | 91010 | United States | Details | |
University of Colorado Hospital - Anschutz Cancer Pavilion | Aurora | Colorado | 80045 | United States | Details | |
Yale School of Medicine | New Haven | Connecticut | 06510 | United States | Details | |
Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 | New York | New York | 10032 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
University of Alberta Hospital | Edmonton | Alberta | T6G 1C9 | Canada | Details | |
Princess Margaret Hospital; Department of Med Oncology | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Jewish General Hospital / McGill University | Montreal | Quebec | H3T 1E2 | Canada | Details |